Entasis’s Competitors, Revenue, Number of Employees, Funding, Acquisitions & News

Entasis is a biotechnology company that develops and commercializes antibiotic therapies for the treatment of bacterial infections. Read more

Entasis is a biotechnology company that develops and commercializes antibiotic therapies for the treatment of bacterial infections. Read more

Manos Perros's photo - President & CEO of Entasis

President & CEO

Manos Perros

CEO Approval Rating

89/100

Founded:

2018

Status:

PublicNASDAQETTX

TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Iterum Therapeutics is Entasis's top competitor. Iterum Therapeutics is headquartered in Dublin, County Dublin, and was founded in 2015. Like Entasis, Iterum Therapeutics also operates in the Biotechnology field. Iterum Therapeutics generates 0.53% the revenue of Entasis.

Spero is seen as one of Entasis's top competitors. Spero's headquarters is in Cambridge, Massachusetts, and was founded in 2013. Spero is in the Pharmaceuticals field. Spero generates 146% of Entasis's revenue.

Tetraphase has been one of Entasis's top competitors. Tetraphase was founded in 2006, and its headquarters is in Watertown, Massachusetts. Like Entasis, Tetraphase also works within the Biotechnology industry. Tetraphase has 34 more employees than Entasis.

Weigh-in!

Help the Owler community know more

Competitor - 1/1

Is Cidara a competitor of Entasis?

Quarterly and Annual Revenue

Coming soon for Entasis!

Annual Revenue

$7M

Entasis's revenue is the ranked 6th among it's top 10 competitors. The top 10 competitors average 35M.

Acquisitions

No recent acquisitions found related to Entasis

Entasis Funding History

$40M$90M$132M$207M$242M

Since Entasis was founded in 2018, it has participated in 8 rounds of funding. In total Entasis has raised $242.0M. Entasis' last funding round was on Jun 2020 for a total of $31.7M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Private Placement
Jun 2020
$31.7M

Innoviva, Inc

Private Placement
Apr 2020
$3.3M
IPO
Sep 2018
$75M
-
Grant
Oct 2017
$3.8M
-
Series B
Sep 2017
$31.9M

Total Funding: $242M

Since Entasis was founded in 2018, it has participated in 8 rounds of funding. In total Entasis has raised $242.0M. Entasis' last funding round was on Jun 2020 for a total of $31.7M

Investments

No recent investments found related to Entasis

Entasis News

July 13, 2020Zacks

Stock Rises 5.4%

Entasis Therapeutics (ETTX) saw a big move last session, as its shares jumped more than 5% on the day... See more »
July 6, 2020BioSpace

Entasis Therapeutics Awarded Contract from National Institutes of Health

Entasis Therapeutics Holdings Inc. (NASDAQ: ETTX), a clinical-stage biopharmaceutical company focused... See more »
June 18, 2020Benzinga

Entasis Therapeutics to Participate in the BMO 2020 Prescriptions for Success Healthcare Conference

WALTHAM, Mass., June 18, 2020 (GLOBE NEWSWIRE) -- Entasis Therapeutics Holdings Inc. (NASDAQ:ETTX), a... See more »
June 12, 2020BioSpace

Entasis Therapeutics Completes Closing of Second Tranche of $35M Private Placement with Innoviva

Entasis Therapeutics Holdings Inc. (NASDAQ: ETTX) ("Entasis"), a clinical-stage biopharmaceutical com... See more »
June 11, 2020firstwordpharma

Entasis Therapeutics Completes Closing of Second Tranche of $35M Private Placement with Innoviva

WALTHAM, Mass., June 11, 2020 (GLOBE NEWSWIRE) -- Entasis Therapeutics Holdings Inc. (NASDAQ: ETTX) (... See more »

Entasis Press Releases

May 7, 2020centralcharts

Entasis Therapeutics Reports First Quarter 2020 Financial Results and Business Update

WALTHAM, Mass., May 07, 2020 (GLOBE NEWSWIRE) -- Entasis Therapeutics Holdings Inc. (NASDAQ: ETTX), a... See more »
October 30, 2019StreetInsider

Entasis Therapeutics Appoints Dr. David Altarac as Chief Medical Officer

Dr. Robin Isaacs to Retire at the End of the Year WALTHAM, Mass., Oct. 30, 2019 (GLOBE NEWSWIRE) -- E... See more »
May 14, 2019GlobeNewswire

Entasis Therapeutics Reports First Quarter 2019 Financial Results and Provides Business Update

Transformative start to the year with the first Phase 3 trial underway and key additions to the leade... See more »
April 30, 2019GlobeNewswire

Entasis Therapeutics to Participate in the 5th Annual SunTrust Robinson Humphrey (STRH) Annual Life Sciences Summit

WALTHAM, Mass., April 30, 2019 (GLOBE NEWSWIRE) -- Entasis Therapeutics Holdings Inc. (NASDAQ: ETTX),... See more »
April 4, 2019streetinsider

Entasis Therapeutics Initiates Global Phase 3 Pivotal Trial of ETX2514SUL for Patients with Carbapenem-Resistant Acinetobacter Infections

WALTHAM, Mass., April 04, 2019 (GLOBE NEWSWIRE) -- Entasis Therapeutics Holdings Inc. (NASDAQ: ETTX),... See more »
April 4, 2019CentralCharts

Entasis Therapeutics Initiates Global Phase 3 Pivotal Trial of ETX2514SUL for Patients with Carbapenem-Resistant Acinetobacter Infections

WALTHAM, Mass., April 04, 2019 (GLOBE NEWSWIRE) -- Entasis Therapeutics Holdings Inc. (NASDAQ: ETTX),... See more »
April 2, 2019GlobalNewswire

Entasis Therapeutics to Present at H.C. Wainwright & Co. Global Life Sciences Conference in London

WALTHAM, Mass., April 02, 2019 (GLOBE NEWSWIRE) -- Entasis Therapeutics Holdings Inc. (NASDAQ: ETTX),... See more »

Headquarters

35 Gatehouse Drive

Waltham, Massachusetts02451

1-781-810-0120

Driving Directions »

Trending Companies

Summary

ABOUT

Overview

Entasis is a biotechnology company that develops and commercializes antibiotic therapies for the treatment of bacterial infections. Entasis was founded in 2018. Entasis' headquarters is located in Waltham, Massachusetts, USA 02451. It has raised 242.0...

CEO

Entasis's President & CEO, Manos Perros, currently has an approval rating of 89%. Entasis's primary competitors are Iterum Therapeutics, Spero & Tetraphase.

Website

entasistx.com

Frequently Asked Questions about Entasis

  1. When was Entasis founded?

    Entasis was founded in 2018
  2. Who is Entasis's CEO?

    Entasis's CEO is Manos Perros
  3. How much revenue does Entasis generate?

    Entasis generates $7M in revenue
  4. How much funding does Entasis have?

    Entasis has historically raised $242M in funding
  1. Where is Entasis's headquarters?

    Entasis's headquarters is in Waltham Massachusetts, USA
  2. How many employees does Entasis have?

    Entasis has 33 employees
  3. What sector does Entasis operate in?

    Entasis is in Biotechnology
  4. Who are Entasis's competitors?

    Entasis's top competitors are Iterum Therapeutics, Spero, Tetraphase